Shandong Boan Biotechnology Co., Ltd. (HKG:6955)
17.60
+0.50 (2.92%)
Last updated: Jul 17, 2025
HKG:6955 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 198.87 | 201.85 | 233.5 | 531.7 | 3.63 |
Short-Term Investments | - | - | - | 81.86 | - |
Cash & Short-Term Investments | 198.87 | 201.85 | 233.5 | 613.56 | 3.63 |
Cash Growth | -1.48% | -13.55% | -61.94% | 16807.19% | - |
Accounts Receivable | 453.6 | 276.2 | 212.12 | 107.27 | 0.7 |
Other Receivables | 60.49 | 16.92 | 14.61 | 18.29 | 30.24 |
Receivables | 514.1 | 293.12 | 226.74 | 125.55 | 30.94 |
Inventory | 168.25 | 165.29 | 143.63 | 98.84 | 19.67 |
Prepaid Expenses | 17.25 | - | - | - | - |
Other Current Assets | 57.82 | 52.75 | 242.81 | 101.9 | 37.82 |
Total Current Assets | 956.28 | 713.01 | 846.68 | 939.85 | 92.06 |
Property, Plant & Equipment | 604.8 | 627.11 | 582.69 | 521.56 | 479.08 |
Other Intangible Assets | 0.08 | 1 | 4.6 | 8.13 | 11.74 |
Long-Term Deferred Charges | 1,243 | 949.51 | 726.9 | 557.87 | 313.53 |
Other Long-Term Assets | 47.22 | 32.77 | 41.69 | 79.19 | 11.63 |
Total Assets | 2,851 | 2,323 | 2,203 | 2,107 | 908.03 |
Accounts Payable | 218.14 | 223.16 | 163.51 | 158.96 | 325.93 |
Accrued Expenses | 92 | 173.48 | 174.84 | 69.58 | 6.65 |
Short-Term Debt | 2 | 23.82 | 22.98 | - | - |
Current Portion of Long-Term Debt | 252.05 | 144.02 | 60.36 | 10 | - |
Current Portion of Leases | 1.79 | 3.57 | 8.38 | 10.02 | 7.65 |
Current Unearned Revenue | 11.42 | 12.35 | 7.02 | 1.29 | - |
Other Current Liabilities | 71.29 | 72.95 | 34.58 | 10.63 | 55.95 |
Total Current Liabilities | 648.68 | 653.35 | 471.67 | 260.48 | 396.18 |
Long-Term Debt | 424.9 | 228.32 | 210 | 240 | - |
Long-Term Leases | 4.81 | 6.18 | - | 4.5 | 8.49 |
Long-Term Unearned Revenue | 5.34 | 3 | - | 1.8 | 2.8 |
Other Long-Term Liabilities | 123.52 | 112.67 | 102.51 | 48.13 | 18.98 |
Total Liabilities | 1,207 | 1,004 | 784.18 | 554.92 | 426.44 |
Common Stock | 535.93 | 509.28 | 509.28 | 498.58 | 360 |
Additional Paid-In Capital | 1,532 | 1,329 | 1,329 | 1,162 | - |
Retained Earnings | -559.26 | -631.11 | -511.06 | -176.1 | -679.6 |
Comprehensive Income & Other | 135.04 | 112.25 | 90.71 | 67.32 | 801.18 |
Shareholders' Equity | 1,644 | 1,320 | 1,418 | 1,552 | 481.59 |
Total Liabilities & Equity | 2,851 | 2,323 | 2,203 | 2,107 | 908.03 |
Total Debt | 685.54 | 405.91 | 301.72 | 264.52 | 16.13 |
Net Cash (Debt) | -486.67 | -204.06 | -68.23 | 349.04 | -12.5 |
Net Cash Per Share | -0.91 | -0.40 | -0.14 | 0.73 | -0.32 |
Filing Date Shares Outstanding | 535.93 | 509.28 | 509.28 | 498.58 | 39.23 |
Total Common Shares Outstanding | 535.93 | 509.28 | 509.28 | 498.58 | 39.23 |
Working Capital | 307.6 | 59.66 | 375 | 679.37 | -304.12 |
Book Value Per Share | 3.07 | 2.59 | 2.79 | 3.11 | 12.28 |
Tangible Book Value | 1,644 | 1,319 | 1,414 | 1,544 | 469.85 |
Tangible Book Value Per Share | 3.07 | 2.59 | 2.78 | 3.10 | 11.98 |
Buildings | 126.38 | 126.38 | 121.38 | 121.21 | 121.02 |
Machinery | 647.65 | 625.81 | 563.21 | 470 | 391.36 |
Construction In Progress | 101.2 | 77.46 | 40.8 | 12.44 | 1.74 |
Updated Sep 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.